StockGlow

Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc.

$28.39-0.03%Healthcare
Compare AVLN with
StockGlow Score
42
Neutral
BearishBullish
1 year ago-4.9%

The outlook

Avalyn Pharma Inc. currently reads as neutral based on below its 50- & 200-day averages, 46% of the way from its 52-week low to high, avg target +108% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range46% of the way from its 52-week low to high
Price targetAvg target +108% vs current price

Analyst price target

~12-month · 4 analysts
$59.00average target+107.8% vs now
Now $28.39
Low $51.00High $80.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$1.26B
52-wk high
$33.32
52-wk low
$24.15
50-day avg
$28.66
200-day avg
$28.70
Trailing P/E
—

Similar stocks

COAGHemab Therapeutics Holdings, Inc.$46.84-1.33%SPTXSeaport Therapeutics, Inc.$20.56+1.16%KLRAKailera Therapeutics, Inc.$16.72-1.94%ODTXOdyssey Therapeutics, Inc.$18.51+0.46%AGMBAgomAb Therapeutics NV$12.54-1.72%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy